Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 22 and 65 years old who have had surgery to remove a brain tumor
- People who have received prior treatments of other kinds (previous TMS — transcranial magnetic stimulation — therapy is the one exception; prior TMS would not be accepted)
- People who have ongoing weakness or movement problems in a limb, starting within 1–2 weeks after surgery, where muscle strength testing shows significant weakness (confirm with trial site for exact scoring details)
- People who are still experiencing long-term movement or physical function problems within three years of their brain surgery
- People who are able to understand the study and are willing to sign a consent form
Who may not be able to join:
- People with any history of seizures
- People who have an implanted medical device, such as a pacemaker, implanted stimulator, electrodes in the brain, or a cochlear implant
- People who had only a brain biopsy, without any tumor removal surgery
- People who have significant memory or thinking difficulties after surgery, as measured by a standard cognitive test (confirm with trial site for exact scoring details)
- People with a history of bipolar disorder
- People who are pregnant or breastfeeding
- People who are currently experiencing thoughts of suicide or have an active plan to harm themselves
- People with a history of moderate to severe heart disease
- People with other neurological conditions involving structural brain damage, such as stroke, multiple sclerosis, other neurodegenerative diseases, or brain infections
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Brian J Gill, MD, Columbia University
Phone: 212-342-5162
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of adverse events and serious adverse events experienced following transcranial magnetic stimulation sessions; Feasibility of transcranial magnetic stimulation in postcraniotomy patients who present with either acute or chronic deficits
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.